PATENT CLAIM ANALYSIS

Application Number: 15949472
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "269100"]

Abstract:
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.

Claim (Index 34):
The method of  claim 29 , wherein the modified angiopoietin is administered in combination with a second therapeutic agent.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.2973
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15414925', '14529677', '15773498', '15820943', '13194854']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7750809506001829
- 35 USC 102 Novelty (BERT): 0.6144379603435887
- Combined Prediction Score: 0.7590166515745235
- Mean Citation Score: 434.05371
- Max Citation Score: 656.813
- Similarity Product: 457.7469625703693

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test